Zhejiang Pharmaceutical: Has repurchased 440,700 shares with a total amount of 5.8959 million yuan.

Zhejiang Pharmaceutical announcement: The company's board of directors approved a share repurchase plan on April 14, 2025, planning to use 100 million to 200 million yuan to repurchase shares through centralized bidding, for employee stock ownership plans or equity incentives. As of May 12, 2025, the company has repurchased a total of 440,700 shares, accounting for 0.05% of the total share capital, with a repurchase price range of 13.31 yuan/share to 13.43 yuan/share, and a total use of funds of 5.8959 million yuan. This repurchase is in compliance with relevant laws and regulations and the company's established plan. The company will continue to implement the repurchase according to market conditions and disclose relevant progress in a timely manner.